Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
European Journal of Biochemistry|October 1, 1984
Nucleotide sequence of the gene for the immunity protein to colicin A. Analysis of codon usage of immunity proteins as compared to colicinsR P Lloubes, M J Chartier, A M Journet, et al.Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|March 1, 1979
[The surgical treatment of thyrotoxic exophthalmos using Ogura's operation (author's transl)]J J Piquet, P François, A Martin, et al.Journal of Chromatography. A|June 13, 2003
Kinetic analysis and subambient temperature on-line on-column derivatization of an active aldehydeR LoBrutto, Y Bereznitski, T J Novak, et al.Life Sciences|January 1, 1997
[3H]benzylpempidine, a new radioligand for probing a putative channel site on nicotinic cholinergic receptorsD X Wang, S S Sheu, V K Sharma, et al.Immunology|November 1, 1996
Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cellsM B Villiers, C L Villiers, M R Jacquier-Sarlin, et al.Revue Des Maladies Respiratoires|January 1, 1987
[Prognostic factors in operated non-small cell cancer of the lung. Study from a randomized therapeutic trial]J Bénichou, C Fabre, C Chastang, et al.Cancer|February 15, 1984
Adjuvant immunotherapy with nonviable Mycobacterium smegmatis in resected primary lung carcinoma. A randomized clinical trial of 219 patientsG Decroix, C Chastang, D Fichet, et al.Revue Des Maladies Respiratoires|January 1, 1984
[Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer]G Decroix, C Chastang, B Lebeau, et al.Revue Francaise Des Maladies Respiratoires|January 1, 1983
[Long-term results of a trial of short-term chemotherapy. French study 6.9.12]G Roussel, M Bernadou, J C Cheminat, et al.Revue Des Maladies Respiratoires|January 1, 1985
[Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment]J C Ansquer, A Bertrand, B Blaive, et al.Pageof 4